A1A44

N-{(2S,4R,5S)-2-hydroxy-2-oxo-4-[(1E,7Z)-tetradeca-1,7-dien-1-yl]-1,3,2lambda~5~-dioxaphosphinan-5-yl}dodecanamide

Created:	2024-09-09
Last modified:	2025-09-10

Find Related PDB Entry
1 entries where A1A44 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	92
Chiral Atom Count	2
Bond Count	92
Aromatic Bond Count	0

2D diagram of A1A44

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-{(2S,4R,5S)-2-hydroxy-2-oxo-4-[(1E,7Z)-tetradeca-1,7-dien-1-yl]-1,3,2lambda~5~-dioxaphosphinan-5-yl}dodecanamide
Systematic Name (OpenEye OEToolkits)	~{N}-[(4~{R},5~{S})-2-oxidanyl-2-oxidanylidene-4-[(~{E})-tetradec-1-enyl]-1,3,2$l^{5}-dioxaphosphinan-5-yl]dodecanamide
Formula	C₂₉ H₅₆ N O₅ P
Molecular Weight	529.732
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	14.52	O=P1(O)OCC(NC(=O)CCCCCCCCCCC)C(/C=C/CCCCCCCCCCCC)O1
SMILES	CACTVS	3.385	CCCCCCCCCCCCC=C[CH]1O[P](O)(=O)OC[CH]1NC(=O)CCCCCCCCCCC
SMILES	OpenEye OEToolkits	2.0.7	CCCCCCCCCCCCC=CC1C(COP(=O)(O1)O)NC(=O)CCCCCCCCCCC
Canonical SMILES	CACTVS	3.385	CCCCCCCCCCCC/C=C/[C@H]1O[P](O)(=O)OC[C@@H]1NC(=O)CCCCCCCCCCC
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCCCCCCCCCCC/C=C/[C@@H]1[C@H](COP(=O)(O1)O)NC(=O)CCCCCCCCCCC
InChI	InChI	1.06	InChI=1S/C29H56NO5P/c1-3-5-7-9-11-13-14-15-17-18-20-22-24-28-27(26-34-36(32,33)35-28)30-29(31)25-23-21-19-16-12-10-8-6-4-2/h22,24,27-28H,3-21,23,25-26H2,1-2H3,(H,30,31)(H,32,33)/b24-22+/t27-,28+/m0/s1
InChIKey	InChI	1.06	WCWADZSYRHRKHD-LVDQGNEYSA-N

Related Resource References

Resource Name	Reference
PubChem	138453938

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.